Nasrin Haghani: Vitamin D and Omega-3 Fatty Acids May Support Mood Regulation
Nasrin Haghani, Surgical Lead Technician at Nuvia Dental Implant Center, shared on LinkedIn:
“Recent research has explored the role of nutrition in mental health, finding that vitamin D and omega-3 fatty acids may significantly support mood regulation. Both nutrients play important biological roles in brain function. Vitamin D influences neurotransmitters such as serotonin, which affects mood stability, while omega-3 fatty acids help maintain the structure of brain cell membranes and support communication between neurons. When levels of these nutrients are low, mood disorders such as depression may become more likely or more severe.
Some clinical studies suggest that supplementation with vitamin D and omega-3s can improve depressive symptoms in certain individuals, particularly those who are deficient. Omega-3 fatty acids, especially EPA and DHA, have been shown to reduce inflammation in the brain, a factor increasingly linked to mood disorders. Vitamin D also supports immune balance and hormonal regulation, which may indirectly influence emotional well-being. These mechanisms help explain why improvements in mood have been observed in some controlled trials when nutritional deficiencies are corrected.
It is important to note that these nutrients are not universal replacements for antidepressant medications, especially in moderate to severe cases. Instead, they may serve as supportive tools within a broader treatment plan that includes professional care, therapy, and healthy lifestyle habits. Balanced nutrition, sunlight exposure, and medical guidance together create a more comprehensive approach to long-term mental health support.”

Stay updated with Hemostasis Today.
-
Jul 8, 2026, 10:29Bringing Hemophilia Care Closer to Communities in Togo – WFH
-
Jul 8, 2026, 10:12Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
-
Jul 8, 2026, 09:58Rola Ghasoub: Early Intracranial Hemorrhage Remains the Main Barrier to Cure in Acute Promyelocytic Leukemia
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV